THE PEA (PALMITOYLETHANOLAMIDE) SUPPLEMENT DEVELOPED BY A BOARD-CERTIFIED PAIN PHYSICIAN
GET THE DOSE USED IN CLINICAL STUDIES–600MG TWICE DAILY
HARNESS THE NATURAL STRENGTH OF THE PALM TREE FOR NERVE HEALTH
OPTIMIZES THREE IMPORTANT SYSTEMS: PPAR alpha receptors to suppress nerve inflammation, Cannabinoid system to modulate the body’s own receptors without marijuana, and Microglial cells aid in nerve regeneration
Qentura P.E.A. is at the cutting edge of nerve supplementation. Palmitoylethanolamide (P.E.A.) was first found to have pain relieving properties for symptoms of sciatica, nerve pain, and neuropathy only within the last decade. Derived from the natural extract of the palm tree, PEA was found to reduce pain from these painful chronic conditions by 61%. Since then its proper use has been restricted to closely held pain physician circles. Until now. At Qentura Dr. Graham, a board certified pain physician, has taken the lessons learned from clinical trials, and his experience with patients to develop a highly absorbed formulation using the actual full doses from these studies.